Becton Dickinson & Co.: Medical Device Recall in 2024 - (Recall #: Z-1026-2024)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2024.

Data Source: FDA.

Product Description:

BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733¿and 231274¿

Product Classification:

Class II

Date Initiated: January 8, 2024

Date Posted: February 14, 2024

Recall Number: Z-1026-2024

Event ID: 93789

Reason for Recall:

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Status: Ongoing

Product Quantity: 2,363,168 total units

Code Information:

Catalog No. 230733¿¿ UDI-DI 00382902307334 Lots 1020750 1116997 1180198 1211448 1277739 1301482 1334126 2025900 2063283 2210054 2277205 3003821 3129527 3263117 9336993 0080290 0178844 0258758; Catalog No. 231274¿ UDI-DI 30382902312742 Lots 2277205 3003821 3129527 3263117 0057245 0080290 1057453 1116997 1148461 1180198 1211448 1277739 1301482 1334126 2025900 2063283 2210054 9336993

Distribution Pattern:

Domestic distribution nationwide. International distribution worldwide.

Voluntary or Mandated:

Voluntary: Firm initiated